TY - JOUR
T1 - Three-dimensional echocardiography for valvular heart disease
T2 - clinical implications
AU - Faza, Nadeen N.
AU - Delgado, Victora
AU - Berrebi, Alain
AU - Zoghbi, William A.
AU - Little, Stephen H.
N1 - Publisher Copyright:
© The Author(s) 2026. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For commercial re-use, please contact [email protected] for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact [email protected]. This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/pages/standard-publication-reuse-rights)
PY - 2026/8/7
Y1 - 2026/8/7
N2 - Three-dimensional (3D) echocardiography has become an essential tool in the evaluation and management of valvular heart disease (VHD), offering superior accuracy and detailed visualization when used with the transthoracic and transoesophageal approaches. The rise of transcatheter valve interventions, particularly for high-risk or inoperable patients, has underscored the importance of 3D imaging in guiding these procedures. 3D echocardiography allows for precise assessment of valvular anatomy, quantification of regurgitation, and visualization of complex lesions, contributing to better procedural planning and outcomes. These advancements have enhanced the ability to guide transcatheter interventions with greater accuracy, improving the overall safety and success of procedures. This review highlights the growing role of 3D echocardiography in the management of VHD, emphasizing its evolving technology and applications in diagnostic precision and procedural guidance.
AB - Three-dimensional (3D) echocardiography has become an essential tool in the evaluation and management of valvular heart disease (VHD), offering superior accuracy and detailed visualization when used with the transthoracic and transoesophageal approaches. The rise of transcatheter valve interventions, particularly for high-risk or inoperable patients, has underscored the importance of 3D imaging in guiding these procedures. 3D echocardiography allows for precise assessment of valvular anatomy, quantification of regurgitation, and visualization of complex lesions, contributing to better procedural planning and outcomes. These advancements have enhanced the ability to guide transcatheter interventions with greater accuracy, improving the overall safety and success of procedures. This review highlights the growing role of 3D echocardiography in the management of VHD, emphasizing its evolving technology and applications in diagnostic precision and procedural guidance.
KW - Structural heart disease interventions
KW - Three-dimensional echocardiography
KW - Valvular heart disease
UR - https://www.scopus.com/pages/publications/105046760819
UR - https://www.scopus.com/inward/citedby.url?scp=105046760819&partnerID=8YFLogxK
U2 - 10.1093/eurheartj/ehaf1127
DO - 10.1093/eurheartj/ehaf1127
M3 - Review article
C2 - 41721505
AN - SCOPUS:105046760819
SN - 0195-668X
VL - 47
SP - 4009
EP - 4031
JO - European heart journal
JF - European heart journal
IS - 30
ER -